在上市后监督后已报告的严重肝脏不良反应事件包括肝坏死、黄疸、伴有或不伴有黄疸的暴发性肝炎、肝衰竭。
Postmarketing surveillance has reported cases of severe hepatic reactions, including liver necrosis, jaundice, fulminant hepatitis with and without jaundice, and liver failure.
潜在的不良反应包括周围神经病变，肌病，乳酸性酸中毒和严重的肝肿大伴脂肪变性，以及-停止治疗后-肝炎恶化。
Potential adverse effects include peripheral neuropathy, myopathy, lactic acidosis and severe hepatomegaly with steatosis, and - after the stopping treatment - worsening of hepatitis.
由于最近牵连到引起一些婴儿严重不良反应，包括呼吸问题、胃肠道紊乱以及一些其他疾病，人工合成 DHA/ARA 正陷入麻烦之中。
Recently implicated in causing severe reactions in some babies, including breathing problems, gastrointestinal upset, and other illnesses, synthetic DHA/ARA is on the hot seat.
应用推荐